Fluoxetine in orthostatic hypotension of Parkinson's disease: A clinical and experimental pilot study

Fundamental and Clinical Pharmacology

Volumn 12, Issue 4, 1998, Pages 398-402

  Montastruc, J L ^a   Pelat, M ^a   Verwaerde, P ^a   Brefel Courbon, C ^a   Tran, M A ^a   Blin, O ^b   Rascol, O ^a   Senard, J M ^a  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Fluoxetine; Orthostatic hypotension; Parkinson's disease; Sino aortic denervation

Indexed keywords

BROMOCRIPTINE; DOPA DECARBOXYLASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; LEVODOPA; LISURIDE; NORADRENALIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DENERVATION; DOG; DOSE RESPONSE; FEMALE; HEART RATE; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031831621     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1998.tb00963.x     Document Type: Article

References (29)

1. Bannister R, Mathias CJ. Autonomic failure: a textbook of clinical disorders of the autonomie nervous system, 3rd edition, vol 1. Oxford: Medical Publications; 1992
2. Chin CK, Roe CJ, Thomas GW. Fluoxetine: a treatment option for severe symptomatic postural hypotension in a diabetic haemodialysis patient. Aust N Z J Med 1996 ; 5 : 714
3. Consensus Committee of the American Autonomie Society and the American Academy of Neurology. Consensus statement of the definition of orthostatic hypotension, pure autonomie failure and multiple system atrophy. Neurology 1996 ; 46 : 1470
4. Durif F, Vidailhet M, Bonnet AM, Blin J, Agid Y. Levodopa-induced dyskinesias are improved by fluoxetine. Neurology 1995 ; 45 : 1855-8
5. Gram LF, Fluoxetine. N Engl J Med 1994 ; 331 : 1354-61
6. Grubb BP, Samoil D, Kosinski D, Kip K, Brewster P. Use of sertraline hydrochloride in the treatment of refractory neurogenic syncope in children and adolescents. J Auton Coll Cardiol 1994 ; 24 : 490-4
7. Grubb BP, Samoil D, Kosinski D, Temesy-Armos P, Akpunonu B. The use of serotonin reuptake inhibitors for the treatment of recurrent syncope due to carotid sinus hypersensibility unresponsive to dual chamber cardiac pacing. PACE 1994 ; 17 : 1434-6
8. Grubb BP, Samoil D, Kosinski D, Wolfe D, Lorton M, Madu E. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am J Med 1994 ; 97 : 366-8
9. Kosinski DJ, Grubb BP, Temesy-Armos PN. The use of serotonin re-uptake inhibitors in the treatment of neurally mediated cardiovascular disorders. J Serotonin Res 1994 ; 1 : 85-90
10. Mets TF. Drug-induced orthostatic hypotension in older patients. Drug Aging 1995 ; 6 : 219-28
11. Montastruc JL, Chamontin B, Senard JM, Tran MA, Rascol O, Llau ME, Rascol A. Pseudopheochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline. Lancet 1993 ; 341 : 555
12. Montastruc JL, Llau ME, Rascol O, Senard JM. Drug-induced parkinsonism: a review. Fundam Clin Pharmacol 1994 ; 8 : 293-306
13. Montastruc JL, Fabre N, Blin O, Senard JM, Rascol O, Rascol A. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study. Mov Disorders 1995 ; 10 : 355-7
14. Montastruc JL, Senard JM, Rascol O, Rascol A. Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. In: Battistin L, Scarlato G, Caracini T, Ruggieri S, eds. Advances in Neurology, vol 69. Philadelphia: Lippincot-Raven Publishers; 1996. p 377-81
15. Montastruc JL, Llau ME, Senard JM, Tran MA, Rascol O, Montastruc P. A study of tolerance to apomorphine. Br J Pharmacol 1996 ; 117 : 781-6
16. Montastruc JL, Laborie I, Bagheri H, Senard JM. Drug-induced orthostatic hypotension: a five-year experience in a regional pharmacovigilance center in France. Clin Drug Invent 1997 ; 14 : 61-5
17. Pfeifer RF. Antiparkinsonian agents. Drug interactions of clinical importance. Drug Safety 1996 ; 14 : 343-54
18. Robertson D, Davis TL. Recent advances in the treatment of orthostatic hypotension. Neurology 1995 ; 45 : S26-32
19. Rutan GH, Hermanson B, Bild DE, Kittner SJ, La Baw F, Tell GS. Orthostatic hypotension in older adults. The cardiovascular health study. Hypertension 1992 ; 19 : 508-19
20. Samoil D, Grubb BP. Neurally mediated syncope and serotonin uptake inhibitors. Clin Auton Res 1995 ; 5 : 251-5
21. Saxena PR. Cardiovascular effects from stimulation of 5-hydroxytryptaminc receptors. Fundam Clin Pharmacol 1989 ; 3 : 245-65
22. Senard JM, Valet P, Durrieu G, Berlan M, Tran MA, Montastruc JL, Rascol A, Montastruc P. Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur J Clin Invest 1990; 20: 613-9
23. Senard JM, Chamontin B, Rascol A, Montastruc JL. Ambulatory blood pressure in patients with Parkinson's disease with and without orthostatic hypotension. Clin Auton Res 1992 ; 2 : 99-104
24. Senard JM, Montastruc JL. Adrenoceptor regulation in orthostatic hypotension during autonomie failure. Trends Pharmacol Sci 1993 ; 14: 349-51
25. Senard JM, Montastruc JL. Which drug for which orthostatic hypotension? Fundam Clin Pharmacol 1996 ; 10 : 225-33
26. Senard JM, Rai S, Lapeyre-Mestre M, Brefel C, Rascol O, Rascol A, Montastruc JL. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997 ; 63 : 584-9
27. Simons JA. Fluoxetine in Parkinson's disease. Mov Disord 1996; 11 : 581-2
28. Valet P, Darnase-Michel C, Montastruc JL, Montastruc P. Plasma catecholamine levels and adrenoceptors after chronic sinoaortic denervation in dogs. Fundam Clin Pharmacol 1989 ; 3 : 307-20
29. Verwaerde P, Senard JM, Mazerolles M, Tran MA, Damase-Michel C, Montastruc JL, Montastruc P. Spectral analysis of blood pressure and heart rate, catecholamine and neuropeptide Y plasma levels in a new model of neurogenic orthostatic hypotension in dogs. Clin Anton Res 1996 ; 6 : 75-82